New tool aims to help blood clot patients choose wisely on blood thinners
NCT ID NCT07659106
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a decision aid for people who have had a first blood clot and must decide whether to stop or continue blood thinners after at least 3 months of treatment. The aid provides balanced information on risks and benefits and helps clarify personal values. Researchers will measure whether it reduces confusion and improves knowledge in 850 participants across 12 Canadian clinics.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Patient decision aid (behavioural intervention)
What this could lead to
If successful, this decision aid could help patients and doctors make more informed, values-based choices about blood thinner use after a first blood clot.
What could go wrong
This is a behavioural study, not a drug trial, so it won't directly treat or cure the condition. The aid may not change outcomes like clot recurrence or bleeding.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY EMBOLISM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ottawa Hospital - General Campus
Ottawa, Ontario, K1H 8L6, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Research Institute of McGill University Health Centre
Montreal, Quebec, H4A 3J1, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Sir Mortimer B. Davis Jewish General Hospital
Montreal, Quebec, H3T 1E2, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Calgary
Calgary, Alberta, T2N 1N4, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Vancouver General Hospital
Vancouver, British Columbia, V5Z 1N1, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact